MiMedx Group a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts. The Company’s proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization.